[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336322-105":59,"doc-detail-336322-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prostatespecific-membrane-antigen-psma-uptake-in-the-scrotum-and-epididymis-on-petct-when-is-it-pathological","Prostate‑Specific Membrane Antigen (PSMA) Uptake in the Scrotum and Epididymis on PET‑CT - When is it Pathological?","","Prostate cancer is the most common solid organ tumor in men and can metastasize to uncommon sites such as the epididymis. Detection of recurrent disease relies on positive emission tomography/computed tomography using the radiotracer 18F-DCFPyL, which binds prostate-specific membrane antigen (PSMA). Although PSMA may be expressed physiologically, metastases typically show more intense PSMA expression and atypical distribution related to overall tumor burden. A MEDLINE search identified only three prior case reports of isolated epididymal metastases.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prostatespecific-membrane-antigen-psma-uptake-in-the-scrotum-and-epididymis-on-petct-when-is-it-pathological/336322/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prostatespecific-membrane-antigen-psma-uptake-in-the-scrotum-and-epididymis-on-petct-when-is-it-pathological/336322.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What imaging approach is used to detect recurrent prostate cancer in this work?","Question",{"text":112,"@type":113},"The work describes positive emission tomography/computed tomography using 18F-DCFPyL binding to prostate-specific membrane antigen (PSMA).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How can physiological epididymal PSMA uptake be distinguished from pathological metastasis?",{"text":117,"@type":113},"The document explains that physiological uptake can occur, but metastases are more likely to show intensely PSMA-expressing lesions with atypical distribution depending on disease burden.",{"name":119,"@type":110,"acceptedAnswer":120},"What do the presented cases show after treatment?",{"text":121,"@type":113},"Case 1 shows resolution of the epididymal metastasis after subsequent management, and follow-up imaging demonstrates resolved PSMA uptake. Case 2 presents a distinct post-treatment clinical scenario with a solitary intensely PSMA-expressing epididymal lesion on PET-CT.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336322,1790781078,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Pictorial Essay  \nProstate‑Specific Membrane Antigen (PSMA) Uptake in the Scrotum and Epididymis on PET‑CT: When is it Pathological?  \nAbstract  \nProstate cancer is the most common solid organ tumor in men and has been reported to metastasize to unusual sites such as the epididymis. The clinical standard for detecting recurrent disease is through positive emission tomography/computed tomography with the radiotracer 18F-DCFPyL binding prostate‑specific membrane antigen (PSMA) expressed by cancerous cells. Although PSMA can also be expressed physiologically, metastases are more likely to be intensely PSMA expressing and in atypical distribution depending on the extent of disease burden in the individual patient. A MEDLINE search revealed only three other case reports of isolated epididymal metastases from prostate cancer diagnosed with prostate‑specific membrane antigen positron emission tomography–computed tomography. This case series comprising both metastatic and physiological PSMA expression in the epididymis provides a useful framework for the interpreting physician when the possibility of this rare but important finding is encountered in prostate cancer imaging.  \nKeywords: Epididymal metastasis, epididymis, prostate cancer, prostate‑specific membrane antigen positron emission tomography–computed tomography   \nIntroduction  \nProstate cancer is the most common solid organ tumor in men, with more than 1 million new cases reported worldwide annually.[1] Prostate cancer can metastasize to any part of the body, with the most common sites including lymph nodes, bones, lungs, liver, and adrenal glands. Several case series and reports have noted metastatic spread of prostate cancer to unusual sites such as the esophagus, eye, periureteric fat, testes, and epididymis.[2,3]  \nProstate‑specific membrane antigen (PSMA) is a transmembrane glycoprotein that has significantly elevated expression in prostate cancer cells, compared to background prostate parenchyma.[4] The development of radiotracer labeled molecules such as 18F-DCFPyL, which selectively bind to the PSMA molecule, has allowed hybrid imaging PSMA positron emission tomography–computed  \ntomography (PET-CT) techniques to emerge as a new clinical standard for the imaging, diagnosis, and staging of metastatic prostate cancer.[5] However, studies have also demonstrated the physiological uptake of PSMA at unusual sites.[6] Examining five  \nThis is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution‑NonCommercial‑ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non‑commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.  \nFor reprints [contact:](contact: WKHLRPMedknow_reprints@wolterskluwer.com)[ WKHLRPMedknow_reprints@wolterskluwer.com](contact: WKHLRPMedknow_reprints@wolterskluwer.com)  \ncases, we present a series of characteristics to differentiate physiological epididymal uptake from epididymal prostate cancer metastasis detected by 18F-DCFPyL-PSMAPET-CT.  \nCase Descriptions (1 and 2, Pathological Cases)  \nCase 1  \nA 73-year-old male presented with a painless right scrotal lump on a background of metastatic prostate adenocarcinoma and arising serum prostate‑specific antigen (PSA) level of 2.8 ug/L, 4 years after undergoing external beam radiotherapy (EBRT) and androgen deprivation therapy for Gleason 4 + 3 = 7 prostate adenocarcinoma. A scrotal ultrasound revealed a 16 mm × 14 mm lesion in the right epididymis, initially thought to represent phlegmonous change secondary to epididymitis. 18F-DCFPyL-PSMA PET-CT revealed an intensely PSMA-expressing lesion in the right epididymis (SUVmax 12) and which was new from previous PSMAPET scans, suggesting a prostate cancer metastasis. [Figure 1] No other sites of metastatic disease were demonstrated. Retrospective review of the previous ultrasound in view of the findings on  \nHow to cite thi","cbCaiidNoOUxzV4H","https://ap.wps.com/l/cbCaiidNoOUxzV4H","pdf",4159870,"English","# Introduction\n# Case Descriptions\n## Case 1\n## Case 2","[{\"question\":\"What imaging approach is used to detect recurrent prostate cancer in this work?\",\"answer\":\"The work describes positive emission tomography/computed tomography using 18F-DCFPyL binding to prostate-specific membrane antigen (PSMA).\"},{\"question\":\"How can physiological epididymal PSMA uptake be distinguished from pathological metastasis?\",\"answer\":\"The document explains that physiological uptake can occur, but metastases are more likely to show intensely PSMA-expressing lesions with atypical distribution depending on disease burden.\"},{\"question\":\"What do the presented cases show after treatment?\",\"answer\":\"Case 1 shows resolution of the epididymal metastasis after subsequent management, and follow-up imaging demonstrates resolved PSMA uptake. Case 2 presents a distinct post-treatment clinical scenario with a solitary intensely PSMA-expressing epididymal lesion on PET-CT.\"}]","Prostate‑Specific Membrane Antigen (PSMA) Uptake in the Scrotum and Epididymis on PET‑CT - When is it Pathological? | PDF",1790014529,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b04f5111b4bc88de6bc42eec52663d1.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27fd541587c40f9c9939ccee89bebb6d.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80299bcf9415608020fae7f3b9967eaf.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/377def3bef9a78db6f40cccb796e269e.webp",980,1268]